NCT05525585

Brief Summary

In this proposed clinical trial, the investigators will randomize 80 very preterm (VPT) infants to receive either early (between day 4 and 7) or delayed (between day 10 and 14) fortification and determine if providing early protein supplementation through early fortification results in higher FFM-for-age z scores and more diversity in the gut microbiome.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 29, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 1, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

November 17, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

November 24, 2025

Status Verified

November 1, 2025

Enrollment Period

12 months

First QC Date

August 29, 2022

Last Update Submit

November 21, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Fat-free mass(FFM)-for-age Z-score

    Estimated by air displacement plethysmography

    Postnatal day 14 to 21

Secondary Outcomes (10)

  • Fecal microbiome composition

    Birth to 36 weeks postmenstrual age

  • Growth - Weight

    Birth to 36 weeks postmenstrual age or hospital discharge

  • Growth - Length

    Birth to 36 weeks postmenstrual age or hospital discharge

  • Growth - Head circumference

    Birth to 36 weeks postmenstrual age or hospital discharge

  • Growth rate

    Birth to 36 weeks postmenstrual age or hospital discharge

  • +5 more secondary outcomes

Study Arms (2)

Early human milk fortification (HMF) group

EXPERIMENTAL

A human milk fortifier will be added to the feeds between days 4 to 7, after a total feeding volume greater than 120 ml/kg/day is achieved.

Dietary Supplement: Early HMF

Delayed human milk fortification (HMF) group

ACTIVE COMPARATOR

A human milk fortifier will be added to the feeds between days 10 to 14, after a total feeding volume greater than 120 ml/kg/day is achieved.

Dietary Supplement: Delayed HMF

Interventions

Early HMFDIETARY_SUPPLEMENT

Mom's milk or donor milk will be fortified between postnatal day 4 and 7

Early human milk fortification (HMF) group
Delayed HMFDIETARY_SUPPLEMENT

Mom's milk or donor milk will be fortified between postnatal day 10 and 14

Delayed human milk fortification (HMF) group

Eligibility Criteria

Age1 Day - 4 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Gestational age 29 to 33 weeks of gestation
  • Birth weight \< 1800 g
  • Postnatal age \< 96 hours

You may not qualify if:

  • Small for gestational age (\<5th percentile)
  • Major congenital/chromosomal anomalies
  • Terminal illness needing withhold or limit support

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham

Birmingham, Alabama, 35233, United States

Location

Related Publications (1)

  • Salas AA, Gunawan E, Jeffcoat S, Nguyen K. Early full enteral nutrition with fortified milk in very preterm infants: a randomized clinical trial. Am J Clin Nutr. 2025 May;121(5):1117-1123. doi: 10.1016/j.ajcnut.2025.02.019. Epub 2025 Feb 21.

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Ariel A. Salas, MD, MSPH

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Pediatrics

Study Record Dates

First Submitted

August 29, 2022

First Posted

September 1, 2022

Study Start

November 17, 2022

Primary Completion

November 1, 2023

Study Completion

May 1, 2026

Last Updated

November 24, 2025

Record last verified: 2025-11

Locations